News Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 13/02/2026 am IST			5-day change	1st Jan Change
40.11 ^USD	-0.99%		-1.86%	+36.01%

06:25pm	Moderna beats quarterly revenue estimates on resilient sales of COVID shot	RE
06:24pm	Moderna announces influenza vaccine filing accepted for regulatory review in the EU	RE

All News

06:25pm	Moderna beats quarterly revenue estimates on resilient sales of COVID shot	RE
06:24pm	Moderna announces influenza vaccine filing accepted for regulatory review in the EU	RE
06:13pm	Moderna beats fourth-quarter revenue estimates	RE
06:02pm	Moderna : Earnings Presentation (ModernaQ25inal)	PU
05:57pm	Moderna's Q4 Net Loss Narrows, Revenue Declines; Reiterates 2026 Revenue Growth Outlook	MT
05:54pm	Moderna beats quarterly revenue estimates on resilient COVID shot sales	RE
05:52pm	Stocks Down Pre-Bell Ahead of Key Inflation Report	MT
05:50pm	Earnings Flash (MRNA) Moderna Posts Q4 Loss $2.11 a Share, vs. FactSet Est of $2.51 Loss	MT
05:48pm	Earnings Flash (MRNA) Moderna, Inc. Reports Q4 Revenue $678.0M, vs. FactSet Est of $635.2M	MT
05:46pm	Moderna: Q4 Earnings Snapshot	AQ
04:48pm	North American Morning Briefing : Stock Futures Slip Ahead of Inflation Data -2-	DJ
06:38am	Vaccines are a national security issue, says global health official	RE
12/02	PRESS DIGEST-New York Times business news - February 12	RE
12/02	Wall Street gains muted after strong jobs data nibbles at Fed rate cut bets	RE
12/02	S&P 500, Dow muted after jobs data; Alphabet, Microsoft drag on Nasdaq	RE
12/02	Wall Street climbs in broad rally after stronger-than-expected jobs report	RE
12/02	Moderna shares pare losses; last down down 3.8%	RE
11/02	Wall St set to open higher after stronger-than-expected jobs report	RE
11/02	Leerink Partners Adjusts Moderna PT to $12 From $17, Maintains Underperform Rating	MT
11/02	Moderna Stock Alert: - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of Moderna Investors - MRNA	NE
11/02	Fda's Vinay Prasad overruled staff to reject Moderna's flu vaccine application - Stat News	RE
11/02	Moderna in a Spin After FDA Declines to Review Flu Vaccine Candidate
11/02	US stock futures stall in run-up to January jobs data	RE
11/02	Goldilocks Jobs, Jittery Markets
11/02	Moderna, Inc. Receives Refusal-To-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, Mrna-1010	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Headlines

Moderna in a Spin After FDA Declines to Review Flu Vaccine Candidate

February 11, 2026 at 08:43 pm IST

Moderna Falls As FDA Vows To Impose New Vaccine Rules

December 02, 2025 at 02:02 am IST